KUNG HANK F has a total of 15 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Taiwan. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ZENTIVA KS, MAPI PHARMA LTD and ANHUI BIOCHEM BIO PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Kung Hank F | 14 |
#2 | Kung Mei-Ping | 6 |
#3 | Zhuang Zhi-Ping | 5 |
#4 | Skovronsky Daniel M | 3 |
#5 | Kung Mei Ping | 3 |
#6 | Trojanowski John Q | 2 |
#7 | Manchanda Rajesh | 1 |
#8 | Qu Wenchao | 1 |
#9 | Thompson Craig B | 1 |
#10 | Y Lee Virginia M | 1 |
Publication | Filing date | Title |
---|---|---|
US2008253967A1 | Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques | |
WO2007002540A2 | Radiolabeled-pegylation of ligands for use as imaging agents | |
WO2007001466A2 | Peptidomimetic somatostatin receptor subtype 2 ligands and pet imaging agents | |
WO0066537A1 | Spect imaging agents for serotonin transporters | |
US5068326A | Dopamine receptor ligands and imaging agents |